Vascular effects and electrolyte homeostasis of the natriuretic peptide isolated from Crotalus oreganus abyssus (North American Grand Canyon rattlesnake) venom  by Da Silva, S.L. et al.
V
f
v
S
G
a
b
c
d
e
f
g
h
i
a
A
R
R
A
A
K
C
H
S
N
N
1
o
v
P
C
F
I
C
(
0
hPeptides 36 (2012) 206–212
Contents lists available at SciVerse ScienceDirect
Peptides
j our na l ho me  p age : www.elsev ier .com/ locate /pept ides
ascular  effects  and  electrolyte  homeostasis  of  the  natriuretic  peptide  isolated
rom  Crotalus  oreganus  abyssus  (North  American  Grand  Canyon  rattlesnake)
enom
.L.  Da  Silvaa,∗,  C.A.  Dias-Juniorb,  P.A.  Baldassoc, D.C.S.  Damicoc, B.M.A.  Carvalhoa, A.  Garantoa,
.  Acosta f,  E.  Oliveirae,  F.  Albericioe,f,g,h, A.M.  Soaresc,  S.  Marangonid, R.R.  Resendei,∗∗
Federal University of São João Del Rei Campus Alto Paraopeba, 36420-000 Ouro Branco, Minas Gerais, Brazil
Universidade Estadual Paulista Júlio de Mesquita Filho, 18618-970 Botucatu, São Paulo, Brazil
Oswaldo Cruz Foundation, Federal University of Rondonia, Porto Velho, Rondônia, Brazil
Department of Biochemistry of Biology Institute, State University of Campinas, Campinas 13083-970, São Paulo, Brazil
Proteomics Platform, Barcelona Science Park, University of Barcelona, 08028 Barcelona, Spain
Institute for Research in Biomedicine, Barcelona Science Park, University of Barcelona, 08028 Barcelona, Spain
CIBER-BBN, Networking Centre on Bioengineering Biomaterials and Nanomedicine, Barcelona Science Park, 08028 Barcelona, Spain
Department of Organic Chemistry, University of Barcelona, 08028 Barcelona, Spain
Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, 31270-901 Belo Horizonte, Minas Gerais, Brazil
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 7 May  2012
eceived in revised form 10 May  2012
ccepted 11 May  2012
vailable online 19 May  2012
eywords:
rotalus oreganus abyssus
ypotensive agents
nake venoms
a  b  s  t  r  a  c  t
Crotalus  oreganus  abyssus  is a rattlesnake  that  is  usually  found  in  the  Grand  Canyon,  United  States  of
America.  Knowledge  regarding  the  composition  of C.  o.  abyssus  venom  is  scarce.  New natriuretic  peptides
(NPs)  have been  isolated  and  characterized  from  the venoms  of  members  of the  Crotalinae  family.  The  NP
family  comprises  three  members,  ANP  (atrial  natriuretic  peptide),  BNP  (b-type  natriuretic  peptide)  and
CNP (c-type  natriuretic  peptide),  and  has  an  important  role  in  blood  pressure  regulation  and  electrolyte
homeostasis.  The aim  of the  present  study  was  to characterize  a  novel  natriuretic-like  peptide  (Coa  NP2),
isolated from  C. o.  abyssus  venom.  The  Coa NP2  presents  an  average  molecular  mass  of  3419.88  Da  (theo-
retical  average  molecular  mass  3418.94  Da,  monoisotopic  molecular  mass  3416.66  Da and theoretical  PI
7.78)  and  its amino  acid  sequence  presents  the loop  region  that  is  characteristic  of  natriuretic  peptides.atriuretc peptides
itric oxide
The  peptide  has  32  amino  acids  and  its  complete  sequence  is SYGISSGCFGLKLDRIGTMSGLGCWRLLQDSP.
Coa NP2  is  a  natriuretic  peptide  of the  ANP/BNP-like  family,  since  the  carboxyterminal  region  of  CNP  has
its own  NP domain.  We  demonstrate,  herein,  that  Coa  NP2  produces  a  dose-dependent  decrease  in mean
arterial  pressure  in  rats,  followed  by  signiﬁcant  increases  in  concentrations  of markers  of nitric  oxide
formation  measured  in  the  plasma  and  vasorelaxation  in  a thoracic  aortic  ring  bath.  The  structural  and
biological  aspects  conﬁrm  Coa NP2  as a new  natriuretic  peptide,  isolated  from  snake  venom.. IntroductionSnake venoms are protein mixtures that act in several physi-
logical systems of their prey or victims. Some effects related to
enomous snake bites can promote tissue damage, myotoxicity,
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hemorrhagic effects, and inﬂammation amongst others [2,6,8].
Many snake venoms contain toxins that produce interesting cardio-
vascular effects, such as hypotension, or bradykinin-potentiating
peptides [15,28], or renal effects [10,39]. Natriuretic peptides (NPs)
are body ﬂuid volume modulators that play important roles in
natriuresis and dieresis [23]. The three mammalian NPs, atrial natri-
uretic peptide (ANP), brain or b-type natriuretic peptide (BNP) and
cardiac or c-type natriuretic peptide (CNP), have been extensively
investigated for their use as therapeutic agents in the treatment of
cardiovascular diseases [1,3,18,22,23,30,31].
Human NPs form a family of structural-similar polypeptides.
Open access under the Elsevier OA license.They have a highly conserved 17-residue intra-molecular disulﬁde
loop (CFGxxxDRIxxxSGLGC), which is important for their biological
activity. Within this cyclic structure, nine amino acids are iden-
tical in all three classes of NPs. However, they differ from each
ptides 36 (2012) 206–212 207
o
a
S
m
d
w
i
s
i
L
t
f
N
k
v
i
o
t
a
i
n
2
C
N
K
2
a
F
S
t
t
a
s
c
s
T
s
2
2
A
b
a
e
a
[
i
p
C
2
o
T
t
D
f
w
u
Fig. 1. (A) Chromatographic proﬁle from the whole venom fraction of C. o. abyssus
eluted by Sephedex G 75 FPLC molecular exclusion. (B) RP-HPLC (C5) chromatogram
of  ﬁltrate from peak V from C. o. abyssus. The peaks containing the natriuretic peptide
(Coa NP1 and Coa NP2) are indicated with an arrow.
of 22 ± 2 ◦C and a relative humidity of 50–60%, under a 12:12 h
light–dark cycle. Animal experiments were performed in accor-S.L. Da Silva et al. / Pe
ther in that they have different numbers of amino acid residues
t the N- and C-terminal portion of the peptide [11,20,23].  In 1992,
chweitz et al. [33] identiﬁed the ﬁrst venom NP from the green
amba  snake, Dendroaspis angusticeps, and named it as the Den-
roaspis natriuretic peptide (DNP). Although DNP shares similarity
ith ANP, it has a distinctly different C-terminal tail. Ho et al. [17]
dentiﬁed and characterized a NP from the South American coral
nake, Micrurus corallines, and reported that it shows some similar-
ties with DNP. Recently, another NP isolated from the venom of the
achesis muta snake (Lm-CNP) was identiﬁed with a similar struc-
ure to human CNP [35]. In addition, a cDNA sequence of Bj-CNP
rom Bothrops jararaca has also been shown to encode a CNP-like
P and seven bradykinin potentiation [28]. On the other hand,
nowledge regarding the composition of Crotalus oreganus abyssus
enom is scarce [24]. From previous experiments in our laboratory
n which we have studied the effects of peptides isolated from C.
. abyssus venom, we showed the presence of a natriuretic pep-
ide in its venom (now called Coa NP1) that produced hypotensive
nd vasorelaxation effects [5].  The aim of the present study was  to
dentify and investigate the systemic and vascular effects of a new
atriuretic peptide isolated from C. o. abyssus venom (Coa NP2).
. Materials and methods
All reagents were purchased from Aldrich or Sigma Co. (USA).
. o. abyssus (Coa) venom was obtained from The National
atural Toxins Research Center (NNTRC) of Texas A&M University-
ingsville (Kingsville, TX, USA).
.1. Isolation and puriﬁcation of the natriuretic peptide from C. o.
byssuss
C. o. abyssus (Coa) whole venom was submitted to an
PLC molecular exclusion chromatographic column packed with
ephadex 75 (Akta Primer, GE, USA), exactly as described in [5].  In
his separation, ﬁve peaks were observed (I–V) (Fig. 1A). Only frac-
ion V presented a hypotensive effect. To perform a better study
nd for separation of peptides and proteins, fraction V was  then
ubmitted to ultra-ﬁltration using the MidJet apparatus (Ge Health-
are, USA), equipped with the UFP-10-C-MM01A cartridge, and a
uperﬁcial area of 26 cm2, cut off: 10,000 Da (Ge Healthcare, USA).
he ﬁltrate presented hypotensive effects and was  lyophilized and
tored at −20 ◦C, until use.
The ﬁltrate was subjected to reverse phase HPLC (model
010, Shimadzu, Japan) using an analytical C5 column (Supelco,
50 mm × 4.6 mm),  which was previously equilibrated with buffer
 (0.1% TFA). The ﬁltrate (10 mg)  were dissolved completely in
uffer A (0.1% TFA), centrifuged at 5000 × g and then loaded onto
 reverse-phase column. The peptides were puriﬁed using a lin-
ar gradient of buffer B concentration (66% acetonitrile in buffer A)
nd the chromatographic UV monitoring was carried out at 216 nm
6,7]. For electrophoresis, Tricine PAGE-SDS was used for character-
zation of low molecular weight proteins and peptides [32]. Each
eak or peak group was tested for its action on blood pressure and
oa NP2 showed positive results.
.2. Sequencing of the Coa NP
Two milligrams of the puriﬁed peptide were dissolved in 200 l
f a 6 mol/l guanidine chloride solution containing 0.4 mol/l of
ris–HCl and 2 mmol/l EDTA (pH 8.15). Nitrogen was  blown over
he top of the protein solution for 15 min, before reducing with
TT (6 M,  200 l). This solution was incubated in the dark at 37 ◦C
or 1 h and desalted using a Sephadex G25 column (0.7 cm × 12 cm)
ith 1 mol/l acetic acid buffer. The reduced peptide was sequenced
sing an automatic peptide sequencer (890C automatic sequencer,Fig. 1 was  modiﬁed from [21]
Beckman, USA). The phenylthyoidantoin (PTH) amino acids were
identiﬁed by comparing their retention times to the 20 PTH amino
acid standards [2].
2.3. MALDI-TOF mass spectrometric analysis (MS)
The molecular mass of isolated Coa-NP was  analyzed by
MALDI-TOF mass spectrometry using a Voyager-DE PRO MALDI-
TOF apparatus (Applied Biosystems, USA). One  microliter of
sample in 0.1% TFA was mixed with 2 l of 3,5-dimethoxy-4-
hydroxycinnamic acid (matrix sinapinic acid). The matrix was
prepared with 30% acetonitrile and 0.1% TFA. Conditions of analysis:
(1) acceleration of voltage 25 kV; (2) laser ﬁxation at 2890 mJ/com2;
(3) delay of 300 ns; and (4) linear analysis mode [2].
2.4. Animals: rats, conditions and ethical statements
Male Wistar rats (250–300 g) were used in this study and were
maintained under speciﬁc pathogen-free conditions. The animals
were housed in laminar-ﬂow cages maintained at a temperaturedance with the ethical guidelines of Helsinki Declaration (1975),
the Institutional Animal Care and Use Ethical Committee of State
University of Campinas (UNICAMP) and the Federal University of
São João Del Rei (UFSJ), both Brazilian universities.
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.5. Blood pressure measurements
Male Wistar rats were anesthetized with 50 mg/kg pentobarbi-
al and, thereafter, the right carotid artery was cannulated with a
olyethylene tube (PE50), under anesthetic conditions (50 mg/kg
f pentobarbital). Mean arterial pressure (MAP) was  continu-
usly recorded for 30 min  using a pressure transducer (P23 Gould
tatham, USA) connected to a polygraph (Narco Biosystems,). After
his time, solutions used as controls and tests (Coa NP2; 0.25
r 0.50 g/ml) were injected (every 15 min) through a catheter
mplanted in the jugular vein Each measurement was compared
ith an isovolumetric injection of saline [10]. Mean arterial pres-
ure (MAP) was calculated by the following formula:
AP = DP + (SP − DP)
3
here MAP  is the mean arterial pressure; SP is the systolic pressure
nd DP is the diastolic pressure.
.6. Aortic ring experiments
Male Wistar rats (250–300 g) were killed and the descending
horacic aorta was rapidly removed and ﬂushed with physiolog-
cal solution. After removal of adhering fat and connective tissue,
 mm rings were obtained from preparations of endothelium-intact
e+) and endothelium-denuded (e−). This latter preparation was
arried out by gently rubbing the vessel’s lumen and mounting
he aortic rings under 1 g resting tension, between two  stainless
teel hooks, in organ baths (37 ◦C, pH 7.4) and bubbling with a
arbogenated (95% O2 and 5% CO2) physiological salt solution of
he following composition (mM):  NaCl: 118.4; NaHCO3: 25; glu-
ose: 11; KCl: 4.7; MgSO4: 1.2; KH2PO4: 1.2; and CaCl2: 2.5. The
ower hook was attached to a tissue holder and the upper hook
as connected to an isometric force displacement transducer (F-
0, Narco Biosystems, Houston, TX, USA); the responses were
ecorded though a 4-channel polygraph (Narco BioSystems, TX,
SA). The aortic rings were submitted to a tension of 1 g dur-
ng a 60-min equilibration period and were considered to have
n intact functional endothelium when acetylcholine (1 mol/l)
roduced a relaxation of more than 80%. Relaxation was calcu-
ated as a percentage of the contraction induced by phenylephrine
PE; 0.1 M)  and concentration–response curves were performed
or NP isolated by C. o. abyssus, Coa NP2 (10−11 to 10−7M),
n both e+ and e− aortic rings. In another set of experiments,
oncentration–response curves for Coa NP2 (10−11 to 10−7M)  were
ompared with phenylephrine precontracted endothelium-intact
issues in the absence or presence of ISATIN (1 M,  a potent
uanylate cyclase-coupled atrial natriuretic peptide receptor type
 antagonist) [13,25] and incubated for 30 min. In the last set of
xperiments, concentration–response curves for Coa NP2 (10−11
o 10−7M)  were performed on aortic rings precontracted with
sosmotic high-potassium (K+ 80 mM)  Krebs–Henseleit solution
10,12].
.7. Determination of plasma NOx (nitrate + nitrite)
oncentrations
After the infusion of Coa NP2 extracted from C. o. abyssus and
he blood pressure assessment, levels of plasma nitrite were mea-
ured by colorimetric Griess methods. In these assays, 50 l of the
amples were incubated with the same volume of Griess reagent
1% sulfanilamide, 0.1% naphthylethylenediamine dihydrochloride
n 5% phosphoric acid). Nitrite levels were determined by compar-
son with a standard curve obtained by incubating sodium nitrate
10–200 M)  with reductase, buffered and measured at 550 nm in a 36 (2012) 206–212
multiwell plate reader (HIDEX, Shimadzu, Japan). The results were
reported as micromolar concentrations (M)  of NO2 [26].
2.8. Measurement of plasma nitrite concentrations
After the infusion of Coa NP2 extracted from C. o. abyssus and the
blood pressure assessment, levels of plasma nitrite were analyzed
in duplicate for their nitrite content using an ozone-based reductive
chemiluminescence assay as previously described [27]. Brieﬂy, to
measure nitrite concentrations in plasma, 100 l of plasma samples
were injected into a solution of acidiﬁed tri-iodide, purging with
nitrogen in-line with a gas-phase chemiluminescence NO analyzer
(Sievers Model 280 NO analyzer, Boulder, CO). Approximately 8 ml
of tri-iodide solution (2 g potassium iodide and 1.3 g iodine dis-
solved in 40 ml  water with 140 ml  acetic acid) was placed in the
purge vessel, into which plasma samples were injected. The tri-
iodide solution reduces nitrites to NO gas, which is detected by the
NO analyzer.
2.9. Theoretical model: computational methods
After the release of the primary sequence of Coa NP2, a
set of homology modeling studies was carried out in order
to obtain tertiary structure information following a previously
described protocol [14]. Initially, a template search was per-
formed by SWISS-MODEL workspace, which identiﬁed several
close homologue-resolved structures by SWISS-MODEL Template
Library (SMTL). As the alignment between the target and the tem-
plates sequences showed high similarity, the automated mode was
chosen to build the tridimensional structure target. The models
were then reﬁned with the AMBER 9.0 package. The models built
were prepared using Leap and submitted to Sander software for
geometry reﬁnement. The models were fully optimized with 1000
steps of steep descent followed by 4000 steps of conjugate gradient.
The minimization processes were performed with a cutoff value of
14 A˚ for non-bonded interactions, implicit solvent generalized Born
model, and using a ff03 force ﬁeld [9].  The ﬁgures for 3D structure
were prepared using the Discovery Studio Visualizer v 2.5, Accelrys
Software Inc. 2009.
2.10. Statistical analysis
Data were analyzed with Student’s t-test for variance. Experi-
mental values are expressed as means ± S.D. The level of statistical
signiﬁcance was  set at a level of p < 0.05.
3. Results
3.1. Isolation and puriﬁcation of the natriuretic peptide from C. o.
abyssus
Fractionation of the whole venom using gel ﬁltration (Sephadex
G-75) produced the elution proﬁle shown in [5].  After ultra-
ﬁltration (cartridge UFP-10-C-MM01A, GE Healthcare), the ﬁltrate
was analyzed by Tricine SDS-PAGE electrophoresis and presented
protein and peptides bands with molecular masses of around or
smaller than 10 kDa. The ﬁltrate decreased blood pressure and was
further puriﬁed by C5-HPLC (Fig. 1B). The RP-HPLC chromatogra-
phy of ﬁltrate demonstrated seven different peaks (or peak groups);
all of these fractions were tested and just two  showed activity by
affecting blood pressure. One peak was identiﬁed as the Coa NP1
(natriuretic peptide 1 from C. o. abyssus) described by [5].  The sec-
ond peak selected was  denominated as Coa NP2 (Fig. 1B). Both
peptides are identiﬁed in the RP-HPLC chromatogram shown in
Fig. 1.
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Table  1
Multiple alignments using the amino acid sequence of Coa NP2 with other natriuretic peptides.
Conse nsus CFG XXXDRI XXXSGLGC Ref
Coa_NP2 
Coa_NP 
NP2_Cdc 
BNP_Bj 
CNP_Bj 
CNP_Lm 
VNOC_Om2 
VNOC_Om 
H-ANP 
H-BNP 
H-CNP
SYGISSGCFGLKL DRIGTM SGLGCWRLLQDSP
(1) 
(2) 
(3) 
(3) 
(4) 
(5) 
(5) 
(6) 
(6) 
(6)
SKRLSNGCFGLKL DRIGAM  SGLG CWRLI NESK 
VSTSRGSQGCFGLKL DRIGAA  SGLGCWRRIVDS 
EVKYDPCFGHKL DRINEV SGLG CPSLRDPRPNAPSTS A 
GAAKGCFGLKL DRIGTM SGLG C
RVGDGCFGLKL DRIGSMSGLGC 
SDPKIGDGCFGLPL  DRIGSV  SGLGCNRPVQNRPKK 
SDSKIGNGCFGFPL  DRIGSV  SGLGCNRPVQNRPKK 
SLRR SSCFGGRMDRIGAQSGL GCNSFRYRR 
SPKMVQGSGCFGRKMDRI SSSSGL GCKVL RRH 
GLSKGCFGLKL  DRIGSMSGLG C
(1) Coa NP1 (natriuretic peptide 1 from C. o. abyssus) (Da Silva et al. [5]); (2) NP2 Cdc (natriuretic peptide from the Crotalus durissus cascavella)  (Evangelista et al. [10]);
( -type 
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a3)  BNP Bj (b-type natriuretic peptide from Bothrops jararaca gland) and CNP Bj (c
NP Lmuta (Lachesis muta CNP) (Soares et al. [35]); (5) VNOC Om and VNOC Om2
human ANP), H-BNP (human BNP) and H-CNP (human CNP) (Schweitz et al. [33]).
The complete amino acid sequence of Coa NP2 was carried
ut by Edman degradation (Table 1) and average molecular mass
3419.88 Da) was conﬁrmed by mass spectrometry (Fig. 2). The
heoretical average molecular mass was 3418.94 Da, monoisotopic
olecular mass was 3416.66 Da and PI was 7.78.
The amino acid sequence of Coa NP presented the loop regionhat is characteristic of natriuretic peptides (17 amino acids – NP
omain consensus = CFGxxxDRIxxxSGLGC) and presented 8 amino
cid residue extensions following the NP domain in the sequence
Table 1). The amino acid sequence of Coa NP2 was identiﬁed as:
ig. 2. The Coa NP2 MALDI-TOF mass spectrometry proﬁle. The average molecular
ass determined is 3419.88 Da. The molecular mass of isolated Coa NP2 from C.
.  abyssus venom was  analyzed using a Voyager-DE PRO MALDI-TOF. (Conditions of
nalysis: acceleration of voltage to 25 kV; laser ﬁxed at 2890 mJ/com2; delay 300 ns;
nd linear analysis mode.)natriuretic peptide from Bothrops jararaca gland) (Hayashi and Camargo [15]); (4)
iuretic peptide from the Oxyuranus micropidotus) (Graham et al. [41]); (6) H-ANP
SYGISSGCFGLKLDRIGTMSGLGCWRLLQDSP (underlined sequence
represents the domain consensus of the NPs). As expected for
natriuretic-like peptides, the primary structure revealed two half
cysteines, suggesting the presence of one disulﬁde bridge (Table 1)
and belongs to the ANP/BNP-like family, since the carboxytermi-
nal regions of c-natriuretic peptides (CNP) end in NP domains. The
experimental results obtained in this study support the hypothesis
that Coa NP2 is really a peptide of either the ANP or BNP families.
3.2. Rat blood pressure, nitric oxide plasma concentrations, and
aortic rings natriuretic peptide isolated from C. o. abyssus venom
(Coa NP2) effects
The natriuretic peptide isolated from C. o. abyssus venom
(Coa NP2) caused a dose-dependent decrease in the median arterial
pressure after its intravenous infusion (Fig. 3).
We observed an increase in the production of plasma NOx
(nitrate + nitrite) concentrations after the infusion of the Coa NP2,
isolated from the C. o. abyssus venom (Fig. 4).
An increase in the production of plasma nitrite concentrations
was also observed after Coa NP2 infusion, isolated from the C. o.
abyssus venom (Fig. 5).
Coa NP2 induced a relaxant effect on endothelium-intact tho-
racic aortic rings that were precontracted with phenylephrine
in the absence and presence of ISATIN. Coa NP2 failed to relax
endothelium-intact aortic rings that were precontracted with an
isosmotic potassium Krebs–Henseleit solution (Fig. 6).
3.3. Theoretical model: computational methods
Unfortunately, when searching for homologous sequences (for
the structural model of Coa NP2), using the Blast tool, no ade-
quate sequences for ANP or BNP were found stored in the RCSB
Protein Data Bank. The best homology (95%) was  achieved with
a CNP complexed with its receptor (1JDP) [16]. To better under-
stand our structure, we  removed the receptor from the global
complex and used the CNP (GLSKGCFGLKLDRIGSMSGLGC) as a
210 S.L. Da Silva et al. / Peptides 36 (2012) 206–212
Fig. 3. Effects of two doses (0.25 g/ml or 0.50 g/ml) of natriuretic peptide 2 iso-
lated from C. o. abyssus (Coa NP2 venom) on mean arterial pressure (mmHg). Results
are  presented as the means ± S.D. of six animals in each group for three independent
experiments. *p < 0.05 for Coa NP2 group compared to the control group.
Fig. 4. Plasma NOx (nitrate + nitrite) concentrations (M) after infusion of natri-
u
g
m
C
i
m
Fig. 5. Plasma nitrite concentrations (nM) after infusion of natriuretic peptide 2,
isolated from C. o. abyssus (Coa NP2 venom). *p < 0.05 for Coa NP2 group, compared
to  the control group.
Fig. 6. Concentration–response curves (%) after infusion of natriuretic peptide 2
isolated from C. o. abyssus (Coa NP2 venom) on intact-endothelium (e+) or denuded-
endothelium (e−) thoracic aortic rings precontracted with phenylephrine (PE;
0.1  M).  The relaxant effect evoked by Coa NP2 (10−11 to 10−7M)  was also com-
pared on endothelium-intact tissues precontracted with PE (0.1 mM)  and incubated
with  ISATIN (1 M), a natriuretic receptor A antagonist, 15 min before performing
concentration–response curves to Coa NP2. The relaxant response was also evalu-
ated in endothelium-intact rings precontracted with an isosmotic 80 mM potassium
+
should be noted; these are probably related to the extensions of
F
D
(
0
rretic peptide 2, isolated from C. o. abyssus (Coa NP2 venom). *p < 0.05 for Coa NP2
roup, compared to the control group.
odel, because its consensus domain is similar to that of the
oa NP2 (SYGISSGCFGLKLDRIGTMSGLGCWRLLQDSP). After apply-
ng the methods of molecular modeling and energy reﬁnement, the
ost probable structure for Coa NP2 is shown in Fig. 7A.
ig. 7. (A) Structure of Coa NP2 from C. o. abyssus venom. (B) Coa NP (red) superimposed
ata  Bank (1JDP). The alignment between the target and the template sequences showed
optimized with 1000 steps of steep descent followed by 4000 steps of conjugate gradie
.54 A˚  and this shows high similarity between both natriuretic peptides from C. o. abyss
eferred to the web  version of the article.)Krebs–Henseleit solution (K 80). The results are expressed as the means ± S.D. of six
independent experiments. *p < 0.05 vs. Coa NP2 intact endothelium group (Coa NP2
e+).
The overlap of Coa NP2 after reﬁnement and use of the CNP
model is shown in Fig. 7B. The structural differences (RMSD 1.79 A˚)the portions C and N terminal Coa NP2 in relation to CNP. The
overlap (RMSD 0.54 A˚) of Coa NP1 and Coa NP2 shows that both
 on CNP (Green). CNP template (RMSD 1.79 A˚) was obtained from the RCSB Protein
 a high similarity (95%). The models were then reﬁned with the AMBER 9.0 package
nt). (C) Coa NP1 (red) superimposed on Coa NP2 (Green). The calculated RMSD is
us. (For interpretation of the references to color in this ﬁgure legend, the reader is
S.L. Da Silva et al. / Peptides
Table  2
Aligment of Coa NP1 and Coa NP2 sequences. Both natriuretic peptides from C. o.
abyssus venom presented approximately 90% of homology. The symbols denoted:
(*)  identical aminoacids and (:) homologous aminoacids.
Coa_NP1         SKRLSNGCFGLKLDRIGAMSGLGCWRLINESK
Coa_NP2         SYGISSGCFGLKLDRIGTMSGLGCWRLLQDSP
m
a
9
4
t
w
p
t
m
3
c
(
p
w
e
s
v
B
s
t
F
i
t
i
e
a
a
w
t
p
t
(
g
b
i
C
h
i
e
a
N
l
s
v
t
s
n
r
w*  :* ***********:*********:::*
olecules have very similar structures (Fig. 7C). The comparative
nalysis between the sequences of Coa NP1 and Coa NP2 show a
0% homology approximately (Table 2).
. Discussion
This study describes the isolation of a new natriuretic pep-
ide from C. o. abyssus venom (Coa NP2), whose primary structure
as determined as SYGISSGCFGLKLDRIGTMSGLGCWRLLQDSP. Its
urity and average molecular mass were conﬁrmed by mass spec-
rometry as being 3419.88 Da (Fig. 2) (the theoretical average
olecular mass is 3418.94 Da, monoisotopic molecular mass is
416.66 Da and PI is 7.78). The primary structure revealed two  half
ysteines, suggesting the presence of one disulﬁde bridge.
Tertiary structure of Coa NP2 prevision, when compared to CNP
human), revealed a RMSD difference of 1.79 A˚ and this effect is
robably caused by the extension of the C-terminal of Coa NP2, but
hen compared to the structure of Coa NP1 [5],  the RMSD differ-
nce is only 0.54 A˚. It was expected because Coa NP1 and Coa NP2
equences have homologies of around 90%.
We found that the natriuretic peptide isolated from C. o. abyssus
enom (Coa NP2) presented a homologous structure to ANP and
NP. Furthermore, the mean functional ﬁndings of this present
tudy were (i) the Coa NP2 produced a dose-dependent decrease in
he mean arterial pressure (Coa NP2 infusion of 0.25 or 0.50 g/ml;
ig. 3); (ii) this hypotensive effect occurred along with a signiﬁcant
ncrease of nitric oxide formation in plasma (Figs. 4 and 5); and (iii)
he vasorelaxation produced by the natriuretic peptide, Coa NP2,
n thoracic aortic rings precontracted with phenylephrine was
ndothelium-dependent. As it was demonstrated by the vasorelax-
tion abolition in endothelium-denuded ring preparations (Fig. 6),
nd (iv) Coa NP2 failed in induce aortic rings relax after precontract
ith 80 mM potassium (Fig. 6).
Snakes venoms contain peptides with structural and func-
ional equivalents of mammalian NPs (ANP, BNP and CNP), which
resent dose-dependent hypotensive effects [10,34,40].  In addition
o natriuretic peptide studies, a 38-amino acid residues peptide
DNP) was isolated from the venom of Dendroaspis angusticeps (the
reen mamba  snake), demonstrating properties that are similar to
oth human ANP and BNP [33]. Other NPs from snake venoms were
dentiﬁed from Lachesis muta (Lm-CNP), Bothrops jararacusu (Bj-
NP) and other snakes presenting a homologous structure for the
uman CNP [28,35].
The hypotensive effect of Coa NP2, presented herein, occurred
n association with a signiﬁcant increase in plasma nitrite lev-
ls, corroborating with previously data suggesting that NPs are
ble to stimulate nitric oxide (NO) production [4].  Together, a
O-dependent hypotensive effect was identiﬁed with a peptide iso-
ated from the snake venom of Agkistrodon acutus [34], and it was
hown that infusion of NP isolated from Crotalus durissus cascavella
enom was responsible for the increased nitrite levels [10]. Thus,
hese ﬁndings support the notion that Coa NP2 exerts its hypoten-
ive action, at least in part, through stimulation of NO production.As such, there are three different receptor isoforms for the NPs,
amely, natriuretic peptide receptor A (NPR-A), natriuretic peptide
eceptor B (NPR-B), and natriuretic peptide receptor C (NPR-C), in
hich the human NP family have been shown natriuretic, diuretic, 36 (2012) 206–212 211
hypotensive and vasodilator actions [20,22]. It has recently been
suggested that BNP exerts its vascular effects through the same
pathway as ANP, i.e. the NPR-A. This guanylate cyclase-coupled
receptor is located both on endothelial and vascular smooth mus-
cle cells [37]. Activation of NPR-A generates the second messenger
cyclic guanosine monophosphate (cGMP) which, in turns, activates
Ca2+ channels and ATP-sensitive K+-channels leading to vasorelax-
ation [21,29].  However, CNP binds to the NPR-B, a speciﬁc guanylate
cyclase-coupled receptor, and it is located on the vascular smooth
muscle cell, also leading to vasodilatation through hyperpolariza-
tion [19].
To evaluate the possible mechanisms responsible for these dose-
dependent hypotensive effects, we  used endothelium-denuded
rings preparations (Coa NP2-e−). It was observed that vasore-
laxation produced by the Coa NP2 in thoracic aortic rings
precontracted with phenylephrine was  endothelium-dependent,
as evidenced by its abolition when it was  used Coa NP2-e−.
(Coa NP2-e+ or Coa NP2-e− group, respectively, Fig. 5). Similar ﬁnd-
ings were revealed by other NPs originated from different snake
venoms [10,38].
The vasorelaxant effect caused by Coa NP2 seems not to be
involved in the NP receptor type A (NPR-A). As the action ver-
iﬁed of the Coa NP2 is not modiﬁed by addition of ISATIN (a
potent guanylate cyclase-coupled NPR-A antagonist) in the aortae
bath (Fig. 6), the failure of Coa NP2 to relax aortic rings pre-
contracted with 80 mM potassium suggested a possible role for
voltage-dependent ion channels that may  include potassium chan-
nels; however, the primary mediator could be calcium inﬂux, which
activates a calcium-activated potassium channel and/or NO release
[13]. Supporting this afﬁrmation, the potassium-channel blocker,
tetraethylammonium has been found to reduce the BNP-induced
dilatation of brachial humans arteries [36]. As such, our ﬁndings
demonstrate that the hypotension and vasodilatation caused by
Coa NP2 is consistent with the hypothesis that both NPR-B path-
ways activate and stimulate NO production in parallel.
In conclusion, we isolated and characterized a new NP-like
peptide from C. o. abyssus venom (Coa NP2), and we also report
a dose-dependent hypotensive effect of this peptide in associ-
ation with increased nitrite production, as well as vasodilatory
endothelium-dependent effects. Therefore, these data suggest that
the NO-release dependent vasodilator action of Coa NP2 may occur
by stimulation of potassium channels.
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